1. Home
  2. SOPH vs YDES Comparison

SOPH vs YDES Comparison

Compare SOPH & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.76

Market Cap

462.3M

Sector

Health Care

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.32

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
YDES
Founded
2011
2013
Country
Switzerland
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.3M
543.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPH
YDES
Price
$5.76
$2.32
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
370.8K
312.1K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.09
N/A
Revenue Next Year
$19.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.92
$1.70
52 Week High
$6.77
$25.00

Technical Indicators

Market Signals
Indicator
SOPH
YDES
Relative Strength Index (RSI) 51.35 44.84
Support Level $4.63 $2.14
Resistance Level $6.30 $3.05
Average True Range (ATR) 0.37 0.32
MACD 0.01 0.07
Stochastic Oscillator 38.89 59.36

Price Performance

Historical Comparison
SOPH
YDES

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: